» Articles » PMID: 29221962

Drug Delivery and Tissue Engineering to Promote Wound Healing in the Immunocompromised Host: Current Challenges and Future Directions

Overview
Specialty Pharmacology
Date 2017 Dec 10
PMID 29221962
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

As regenerative medicine matures as a field, more promising technologies are being translated from the benchtop to the clinic. However, many of these strategies are designed with otherwise healthy hosts in mind and validated in animal models without other co-morbidities. In reality, many of the patient populations benefiting from drug delivery and tissue engineering-based devices to enhance wound healing also have significant underlying immunodeficiency. Specifically, patients suffering from diabetes, malignancy, human immunodeficiency virus, post-organ transplantation, and other compromised states have significant pleotropic immune defects that affect wound healing. In this work, we review the role of different immune cells in the regenerative process, highlight the effect of several common immunocompromised states on wound healing, and discuss different drug delivery strategies for overcoming immunodeficiencies.

Citing Articles

The landscape of biofilm models for phage therapy: mimicking biofilms in diabetic foot ulcers using 3D models.

Martinet M, Thomas M, Bojunga J, Pletz M, Vehreschild M, Wurstle S Front Microbiol. 2025; 16:1553979.

PMID: 40066272 PMC: 11891221. DOI: 10.3389/fmicb.2025.1553979.


Dual-layer microneedles with NO/O releasing for diabetic wound healing via neurogenesis, angiogenesis, and immune modulation.

Liu C, Liu K, Zhang D, Liu Y, Yu Y, Kang H Bioact Mater. 2025; 46():213-228.

PMID: 39802419 PMC: 11719290. DOI: 10.1016/j.bioactmat.2024.12.012.


Reconstructive Surgery of the Head and Neck in Organ Transplant Recipients: A Case Report and a Review of the Literature.

Rampi A, Comini L, Galli A, Howardson B, Tettamanti A, Luparello P J Clin Med. 2024; 13(16).

PMID: 39200933 PMC: 11355776. DOI: 10.3390/jcm13164790.


Skin repair and infection control in diabetic, obese mice using bioactive laser-activated sealants.

Pallod S, Aguilera Olvera R, Ghosh D, Rai L, Brimo S, DeCambra W Biomaterials. 2024; 311:122668.

PMID: 38908232 PMC: 11562812. DOI: 10.1016/j.biomaterials.2024.122668.


Surface Modification Progress for PLGA-Based Cell Scaffolds.

Yan B, Hua Y, Wang J, Shao T, Wang S, Gao X Polymers (Basel). 2024; 16(1).

PMID: 38201830 PMC: 10780542. DOI: 10.3390/polym16010165.


References
1.
Yenilmez E, Basaran E, Arslan R, Berkman M, Guven U, Baycu C . Chitosan gel formulations containing egg yolk oil and epidermal growth factor for dermal burn treatment. Pharmazie. 2015; 70(2):67-73. View

2.
Felts A, Giridhar G, Grainger D, Slunt J . Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model. Burns. 1999; 25(5):415-23. DOI: 10.1016/s0305-4179(99)00017-0. View

3.
Vasconcelos D, Costa M, Amaral I, Barbosa M, Aguas A, Barbosa J . Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators. Biomaterials. 2014; 37:116-23. DOI: 10.1016/j.biomaterials.2014.10.035. View

4.
Mirza R, Fang M, Weinheimer-Haus E, Ennis W, Koh T . Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. 2013; 63(3):1103-14. PMC: 3931398. DOI: 10.2337/db13-0927. View

5.
ROBSON M, PHILLIPS L, Thomason A, Robson L, Pierce G . Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 1992; 339(8784):23-5. DOI: 10.1016/0140-6736(92)90143-q. View